ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977

Cedars-Sinai Develops Criteria For FDG-PET In Breast Cancer

August 25, 2006

NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years

May 1, 1987

Benacerraf Named Farber President

February 8, 1980